Base excision repair genes XRCC1 and APEX1 and the risk for prostate cancer

Molecular Biology Reports

Volumn 38, Issue 3, 2011, Pages 1585-1591

  Kuasne, H ^a   Rodrigues, I S ^a   Losi Guembarovski, R ^a   Reis, M B ^a   Fuganti, P E ^b   Gregorio E P ^b   Libos Jr , F ^b   Matsuda, H M ^a   Rodrigues, M A F ^a   Kishima, M O ^a   Colus I M S ^a  

^a STATE UNIVERSITY OF LONDRINA   (Brazil)

^b UNIVERSITY OF LONDRINA   (Brazil)

Author keywords

APEX1; Polymorphisms; Prostate cancer; Repair genes; XRCC1

Indexed keywords

DNA;

AGED; APEX1 GENE; ARTICLE; CANCER RISK; CARCINOGENESIS; CASE CONTROL STUDY; CONTROLLED STUDY; DNA DETERMINATION; EXCISION REPAIR; GENE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PROSTATE CANCER; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; XRCC1 GENE;

CASE-CONTROL STUDIES; DNA REPAIR; DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE; DNA-BINDING PROTEINS; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; NEOPLASM STAGING; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RISK FACTORS;

EID: 79951577012     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-010-0267-z     Document Type: Article

References (39)

1. INCA: Instituto Nacional do Câncer. http://www.inca.gov.br/ estimativa/2010. Accessed 26 February 2010
2. H Hirata Y Hinoda Y Tanaka N Okayama Y Suehiro K Kawamoto N Kikuno S Majid K Vejdani R Dahiya 2007 Polymorphisms of DNA repair genes are risk factors for prostate cancer Eur J Cancer 43 2 231 237 1:CAS:528:DC%2BD2sXpvVKkug%3D%3D 10.1016/j.ejca.2006.11.005 17196815 (Pubitemid 46123995)
3. MR Shen IM Jones H Morenweiser 1998 Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans Cancer Res 58 604 608 1:CAS:528:DyaK1cXht1antLo%3D 9485007 (Pubitemid 28099464)
4. T Xi IM Jones HW Mohrenweiser 2004 Many amino acid substitution variants identified in DNA repair genes during human population screenings are predicted to impact protein function Genomics 83 970 979 1:CAS:528:DC%2BD2cXksFKisL0%3D 10.1016/j.ygeno.2003.12.016 15177551 (Pubitemid 38726046)
5. RJ Hung J Hall P Brennan P Boffetta 2005 Genetic polymorphisms in the base excision repair pathway and cancer risk: a HuGE review Am J Epidemiol 162 10 925 942 10.1093/aje/kwi318 16221808 (Pubitemid 41619464)
6. Y Kubota RA Nash A Klungland P Schar DE Barnes T Lindahl 1996 Reconstitution of DNA base excision-repair with purified human proteins: interaction between DNA polymerase b and the XRCC1 protein EMBO J 15 6662 6670 1:CAS:528:DyaK2sXht1Oqt7k%3D 8978692 (Pubitemid 26413798)
7. LH Thompson MG West 2000 XRCC1 keeps DNA from getting stranded Mutat Res 459 1 18 1:CAS:528:DC%2BD3cXhtFaks7s%3D 10677679 (Pubitemid 30085463)
8. KW Caldecott S Aoufouchi P Johnson S Shall 1996 XRCC1 polypeptide interacts with DNA polymerase b and possibly poly(ADP-ribose) polymerase, and DNA ligase III is a novel molecular 'nick-sensor' in vitro Nucleic Acids Res 24 4387 4394 1:CAS:528:DyaK28Xnt12ktb8%3D 10.1093/nar/24.22.4387 8948628 (Pubitemid 26388624)
9. Z Xu LX Hua LX Qian J Yang XR Wang W Zhang HF Wu 2007 Relationship between XRCC1 polymorphisms and susceptibility to prostate cancer in men from Han, Southern China Asian J Androl 9 3 331 338 1:CAS:528:DC%2BD2sXms1Ohurc%3D 10.1111/j.1745-7262.2007.00263.x 17486273 (Pubitemid 47097288)
10. BA Rybicki DV Conti A Moreira M Cicek G Casey JS Witte 2004 DNA repair gene XRCC1 and XPD polymorphisms and risk of prostate cancer Cancer Epidel Biom Prev 13 1 23 29 1:CAS:528:DC%2BD2cXmsVWhug%3D%3D 10.1158/1055-9965.EPI-03-0053 (Pubitemid 38116616)
11. L Chen CB Ambrosone J Lee TA Sellers J Pow-sang JY Park O Popanda 2006 Association between polymorphisms in the DNA repair genes XRCC1 and APE1, and the risk of prostate cancer in white and black Americans J Urol 175 108 112 1:CAS:528:DC%2BD28XntlWksQ%3D%3D 10.1016/S0022-5347(05)00042-X 16406883 (Pubitemid 41797104)
12. C Casse YC Hu SA Ahrendt 2003 The XRCC1 codon 399Gln allele is associated with adenine to guanine p53 mutations in non-small cell lung cancer Mutat Res 528 19 27 1:CAS:528:DC%2BD3sXlsVahsLw%3D 12873719 (Pubitemid 36859792)
13. EJ Duell JK Wiencke TJ Cheng A Varkonyi ZF Zuo TD Ashok, et al. 2000 Polymorphisms in the DNA repair genes XRCC1 and ERCC2 and biomarkers of DNA damage in human blood mononuclear cells Carcinogenesis 21 965 971 1:CAS:528:DC%2BD3cXjsFyht7g%3D 10.1093/carcin/21.5.965 10783319 (Pubitemid 30265141)
14. RM Lunn RG Langlois LL Hsieh CL Thompson DA Bell 1999 XRCC1 polymorphisms: effects on aflatoxin B1-DNA adducts and glycophorin A variant frequency Cancer Res 59 2557 2561 1:CAS:528:DyaK1MXjs1ymsLk%3D 10363972 (Pubitemid 29269097)
15. DS Chen T Herman B Demple 1991 Two distinct human DNA diesterases that hydrolyze 3V-blocking deoxyribose fragments from oxidized DNA Nucleic Acids Res 9 21 5907 5914 10.1093/nar/19.21.5907 (Pubitemid 21913003)
16. B Demple L Harrison 1994 Repair of oxidative damage to DNA: enzymology and biology Ann Rev Biochem 63 915 948 1:CAS:528:DyaK2MXitlCgtA%3D%3D 10.1146/annurev.bi.63.070194.004411 7979257 (Pubitemid 24218652)
17. AR Evans M Limp-Foster MR Kelley 2000 Going APE over ref-1 Mutat Res 461 2 83 108 1:CAS:528:DC%2BD3cXntVWgtb4%3D 11018583
18. JJ Hu TR Smith MS Miller HW Mohrenweiser A Golden LD Case 2001 Amino acid substitution variants of APE1 and XRCC1 genes associated with ionizing radiation sensitivity Carcinogenesis 22 6 917 922 1:CAS:528:DC%2BD3MXktlSks7g%3D 10.1093/carcin/22.6.917 11375899 (Pubitemid 32514958)
19. MR Kelley L Cheng R Foster R Tritt J Jiang J Broshears M koch 2001 Elevated and altered expression of the multifunctional DNA base excision repair and redox enzyme Ape1/ref-1 in prostate cancer Clin Cancer Res 7 4 824 830 1:CAS:528:DC%2BD3MXjs1elsr0%3D 11309329 (Pubitemid 32708717)
20. D Gu M Wang M Wang Z Zhang J Chen 2009 The DNA repair gene APE1 T1349G polymorphism and cancer risk: a meta-analysis of 27 case-control studies Mutagenesis 24 6 507 512 1:CAS:528:DC%2BD1MXhtlyrtrnL 10.1093/mutage/gep036 19762350
21. AV Carrano AT Natarajana 1988 International commission for protection against environmental mutagens and carcinogens ICPEMC publication no. 14. Considerations for population monitoring using cytogenetic techniques Mutat Res 204 379 406 1:STN:280:DyaL1c7ls1ymsg%3D%3D 10.1016/0165-1218(88)90036-5 3347212 (Pubitemid 18072333)
22. SA Miller DD Dykes HF Polesky 1988 A simple salting out procedure for extraction DNA from human nucleated cell Nucleic Acids Res 16 1215 1:CAS:528:DyaL1cXhsVKlsrs%3D 10.1093/nar/16.3.1215 3344216
23. DF Gleason 1992 Histologic grading of prostate cancer: a perspective Human Path 23 273 279 1:STN:280:DyaK383htVWjug%3D%3D 10.1016/0046-8177(92)90108- F
24. AJCC/UICC-American Joint Committee on Cancer/International Union Against Cancer. http://www.uicc.org. Accessed 16 June 2009
25. AV D'Amico R Whittington SB Malkowicz J Ondurulia MH Chen JE Tomaszewski 1998 The combination of preoperative prostate specific antigen and postoperative pathological findings to predict prostate specific antigen outcome in clinically localized prostate cancer J Urol 160 6 Pt 1 2096 2101 9817331 (Pubitemid 128703621)
26. Ayres M, Ayres Jr M, Ayres DL, Santos AS. BioEstat Version.5. Civil Society MCT Mamirauá - CNPq. Belem, Pará, Brasil
27. Braile DM and Godoy MF. Odds Ration Calculater. Braile Biomedics. São José do Rio Preto, São Paulo, Brasil
28. SA Weitzman LI Gordon 1990 Inflammation and cancer: role of phagocyte-generated oxidants in carcinogenesis Blood 76 655 663 1:CAS:528:DyaK3cXls12ls7o%3D 2200535 (Pubitemid 20253278)
29. H Bartsch N Frank 1996 Blocking the endogenous formation of N-nitroso compounds and related carcinogens IARC Sci Publ 139 189 201 1:CAS:528: DyaK28Xnt1SmsLw%3D 8923031
30. K Shinmura S Yamaguchi T Saitoh, et al. 2001 Somatic mutations and single nucleotide polymorphisms of base excision repair genes involved in the repair of hydroxyguanine in damaged DNA Cancer Lett 166 1 65 69 1:CAS:528: DC%2BD3MXisVaksro%3D 10.1016/S0304-3835(01)00435-9 11295288 (Pubitemid 32274286)
31. R Gao DK Price T Sissung E Reed WD Figg 2008 Ethnic disparities in Americans of European descent versus Americans of African descent related to polymorphic ERCC1, ERCC2, XRCC1, and PARP1 Mol Cancer Ther 7 5 1246 1250 1:CAS:528:DC%2BD1cXlvFamsrY%3D 10.1158/1535-7163.MCT-07-2206 18483312
32. FC Parra RC Amado JR Lambertucci J Rocha CM Antunes SDJ Pena 2002 Color and genomic ancestry in Brazilians Genetics 100 177 182 (Pubitemid 36078048)
33. AE Vidal S Boiteux I-D Hickson J-P Radicella 2001 XRCC1 coordinates the initial and late stages of DNA abasic site repair through protein-protein interactions EMBO J 20 6530 6539 1:CAS:528:DC%2BD3MXovFOnur4%3D 10.1093/emboj/20.22.6530 11707423 (Pubitemid 33078725)
34. J Geng Q Zhang C Zhu J Wang L Chen 2009 XRCC1 genetic polymorphism Arg399Gln and prostate cancer risk: a meta-analysis Urology 74 3 648 653 10.1016/j.urology.2009.02.046 19428062
35. T Farkasova S Gurska V Witkovsky A Gabelova 2008 Significance of amino acid substitution variants of DNA repair genes in radiosusceptibility of cervical cancer patients; a pilot study Neoplasma 55 4 330 337 1:CAS:528:DC%2BD1cXovFOjtLc%3D 18505345
36. M Kasahara K Osawa K Yoshida A Miyaishi Y Osawa N Inoue A Tsutou Y Tabuchi K Tanaka M Yamamoto E Shimada J Takahashi 2008 Association of MUTYH Gln324His and APEX1 Asp148Glu with colorectal cancer and smoking in a Japanese population J Exp Clin Cancer Res 27 49 10.1186/1756-9966-27-49 18823566
37. H Ito K Matsuo N Hamajima T Mitsudomi T Sugiura T Saito T Yasue KM Lee D Kang KY Yoo S Sato R Ueda K Tajima 2004 Gene-environment interactions between the smoking habit and polymorphisms in the DNA repair genes, APE1 Asp148Glu and XRCC1 Arg399Gln, in Japanese lung cancer risk Carcinogenesis 25 8 1395 1401 1:CAS:528:DC%2BD2cXmtF2nt70%3D 10.1093/carcin/bgh153 15044328 (Pubitemid 39162705)
38. FC Hamdy 2001 Prognostic and predictive factors in prostate cancer Cancer Treat Rev 27 3 143 151 1:STN:280:DC%2BD3Mzls1Wmsg%3D%3D 10.1053/ctrv.2000.0208 11417964 (Pubitemid 32452014)
39. PP Chatelard 2002 Standards options and recommendations for the management of prostate cancer: therapeutic decision criteria Bull Cancer 89 6 619 634 12135863